Sarah Psutka Department of Urology University of Washington Biography Publications Institution JoVE Articles Sarah Psutka has not added a biography. If you are Sarah Psutka and would like to personalize this page please email our Author Liaison for assistance. Publications Advances in the Characterization of Clear Cell Papillary Renal Cell Carcinoma: Identifying the Sheep in Wolf's Clothing European Urology. Apr, 2021 | Pubmed ID: 33579573 Patterns and Timing of Perioperative Blood Transfusion and Association with Outcomes After Radical Cystectomy Urologic Oncology. Feb, 2021 | Pubmed ID: 33551249 Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries With Muscle Invasive Bladder Cancer From 2004-2015 Urology. Mar, 2021 | Pubmed ID: 33373709 Female Authorship Trends in Urology During the COVID-19 Pandemic European Urology. 02, 2021 | Pubmed ID: 33250302 Prostate Cancer Presentation, Treatment Selection, and Outcomes Among Men with HIV/AIDS: A Clinical Stage, Race, and Age-matched Contemporary Analysis Urologic Oncology. 01, 2021 | Pubmed ID: 32843291 Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program Clinical Genitourinary Cancer. Oct, 2020 | Pubmed ID: 33160889 Quantification of Body Composition in Renal Cell Carcinoma Patients: Comparing Computed Tomography and Magnetic Resonance Imaging Measurements European Journal of Radiology. Nov, 2020 | Pubmed ID: 33010681 Women in Leadership in Urology: The Case for Increasing Diversity and Equity Urology. Sep, 2020 | Pubmed ID: 32961220 Assessing Contemporary Trends in Female Speakership Within Urologic Oncology Urology. Aug, 2020 | Pubmed ID: 32798517 Introduction: Personalizing Risk Stratification in Bladder Cancer: Moving Away from "the Eyeball Test" and Embracing Objective Quantification of Risk Urologic Oncology. 09, 2020 | Pubmed ID: 32600927 Personalizing Preoperative Risk Stratification and Refining Patient Selection for Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Cancer. Sep, 2020 | Pubmed ID: 32515836 Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients American Journal of Therapeutics. May, 2020 | Pubmed ID: 32384317 Risk Stratification Metrics for Bladder Cancer: Comprehensive Geriatric Assessments Urologic Oncology. 09, 2020 | Pubmed ID: 32037198 Xanthogranulomatous Pyelonephritis With Direct Extension Into the Liver The American Journal of Medicine. 09, 2020 | Pubmed ID: 31991112 Overdiagnosis and Lives Saved by Reflex Testing Men With Intermediate Prostate-Specific Antigen Levels Journal of the National Cancer Institute. 04, 2020 | Pubmed ID: 31225597 Reply by Authors The Journal of Urology. 11, 2019 | Pubmed ID: 31364930 Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and Communication The Journal of Urology. 11, 2019 | Pubmed ID: 31112106 Reassessing the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in 2019 American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. Jan, 2019 | Pubmed ID: 31099657 MRI Quantitation of Abdominal Skeletal Muscle Correlates with CT-based Analysis: Implications for Sarcopenia Measurement Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme. Aug, 2019 | Pubmed ID: 30615474 Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients European Urology Oncology. 09, 2018 | Pubmed ID: 31100250 Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer Bladder Cancer (Amsterdam, Netherlands). Oct, 2018 | Pubmed ID: 30417052 Unraveling Associations Between Occupation and Bladder Cancer Aggressiveness: Describing the Landscape European Urology Focus. 09, 2018 | Pubmed ID: 30154044 Segmentering og lineær måling for kroppssammensetningsanalyse ved hjelp av Slice-O-Matic og Horos Sean Steele1, Fangyi Lin1, Thien-Linh Le1, Alexandra Medline1, Michelle Higgins1, Alex Sandberg1, Sean Evans1, Gordon Hong2, Milton A. Williams3, Mehmet A. Bilen4, Sarah Psutka5, Kenneth Ogan1, Viraj A. Master1 1Department of Urology, Emory University School of Medicine, 2Northeast Ohio Medical University, 3Department of Urology, University of Alabama at Birmingham, 4Department of Medical Oncology, Winship Cancer Institute of Emory University, 5Department of Urology, University of Washington JoVE 61674 Medicine
Segmentering og lineær måling for kroppssammensetningsanalyse ved hjelp av Slice-O-Matic og Horos Sean Steele1, Fangyi Lin1, Thien-Linh Le1, Alexandra Medline1, Michelle Higgins1, Alex Sandberg1, Sean Evans1, Gordon Hong2, Milton A. Williams3, Mehmet A. Bilen4, Sarah Psutka5, Kenneth Ogan1, Viraj A. Master1 1Department of Urology, Emory University School of Medicine, 2Northeast Ohio Medical University, 3Department of Urology, University of Alabama at Birmingham, 4Department of Medical Oncology, Winship Cancer Institute of Emory University, 5Department of Urology, University of Washington JoVE 61674 Medicine